SEI Investments’s Solid Biosciences SLDB Stock Holding History

SEI Investments’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$131K	Hold	13,078	–	–	﹤0.01%	3142
2026 Q1	$94.2K	Hold	13,078	–	–	﹤0.01%	3106
2025 Q4	$73.8K	Hold	13,078	–	–	﹤0.01%	3044
2025 Q3	$80.7K	Hold	13,078	–	–	﹤0.01%	2739
2025 Q2	$63.7K	Hold	13,078	–	–	﹤0.01%	2733
2025 Q1	$48.4K	Hold	13,078	–	–	﹤0.01%	2679
2024 Q4	$52.3K	Buy	+13,078	New	+$71.8K	﹤0.01%	2660

Other funds holding SLDB

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SEI Investments's SLDB Position: Q2 2026 in Review

SEI Investments held its Solid Biosciences (SLDB) position steady in Q2 2026 at 13,078 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #3142.

SEI Investments first reported a position in SLDB in Q4 2024 and has held it in 7 quarters since. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

SEI Investments held 13,078 shares of Solid Biosciences worth $131K as of Q2 2026.
SEI Investments left its Solid Biosciences share count unchanged in Q2 2026.
Solid Biosciences made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #3142 holding.
SEI Investments first reported a position in Solid Biosciences in Q4 2024 and has held it in 7 quarters since.
157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.